Literature DB >> 4762552

Cross-stimulation of monoclonal antibodies in anamnestic responses.

M Cramer, D G Braun.   

Abstract

Immunization of BALB/c mice with Group A streptococcal vaccines leads to the induction of high levels of monoclonal antibody populations. Subsequent immunization of these mice with Group A-variant streptococcal vaccines induces a significant level of monoclonal antibody of A-variant antigen specificity revealed by labeled group A-variant polysaccharide. During these course Av and Av' immunizations, the monoclonal Group A-specific antibodies were also restimulated to levels usually higher than the variant-specific antibodies. With two exceptions, these homogeneous antibody populations were not cross-reactive in vitro with the related antigen. Such cross-stimulation of monoclonal antibodies was interpreted as a function of particular membrane properties of the Ig receptor-bearing memory cells which, for restimulation, would only require the structurally closely related antigen which serves as a backbone to the original antigen, and not necessarily the exact fit of the homologous immunodominant group.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4762552      PMCID: PMC2139463          DOI: 10.1084/jem.138.6.1533

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  Antibody responses after successive injections of related antigens.

Authors:  R V GILDEN
Journal:  Immunology       Date:  1963-01       Impact factor: 7.397

2.  Influenza: the new acquayantance.

Authors:  T FRANCIS
Journal:  Ann Intern Med       Date:  1953-08       Impact factor: 25.391

3.  Original antigenic sin at the cellular level. I. Antibodies produced by individual cells against cross-reacting haptens.

Authors:  S Deutsch; A E Bussard
Journal:  Eur J Immunol       Date:  1972-08       Impact factor: 5.532

4.  Streptococcal group A carbohydrate antibodies in mice: evidence for strain differences in magnitude and restriction of the response, and for thymus dependence.

Authors:  D G Braun; B Kindred; E B Jacobson
Journal:  Eur J Immunol       Date:  1972-04       Impact factor: 5.532

5.  Evidence of functional microenvironments in lymphatic tissue response to antigen.

Authors:  M G Hanna; P Nettesheim; L C Peters
Journal:  Nat New Biol       Date:  1971-08

6.  Idiotypic identity of antibodies to streptococcal carbohydrate in inbred mice.

Authors:  K Eichmann
Journal:  Eur J Immunol       Date:  1972-08       Impact factor: 5.532

7.  Amino acid sequence of the N-terminal sixty-nine residues of heavy chain derived from a homogeneous rabbit antibody.

Authors:  J C Jaton; D G Braun
Journal:  Biochem J       Date:  1972-11       Impact factor: 3.857

8.  Mouse antibodies to group A streptococcal carbohydrate; use of idiotypy to detect inbred strain specificity and to monitor spleen cell transfer in syngenetic mice.

Authors:  D E Briles; R M Krause
Journal:  J Immunol       Date:  1972-12       Impact factor: 5.422

9.  Studies on the chemical structure of the streptococcal cell wall. I. The identification of a mucopeptide in the cell walls of groups A and A-variant streptococci.

Authors:  R M KRAUSE; M MCCARTY
Journal:  J Exp Med       Date:  1961-07-01       Impact factor: 14.307

10.  Idiotypic specificity of rabbit antibodies to streptococcal group polysaccharides.

Authors:  D G Braun; A S Kelus
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

View more
  2 in total

1.  Antibodies to Mycobacterium tuberculosis-specific epitopes in lepromatous leprosy.

Authors:  G Bothamley; J S Beck; W Britton; A Elsaghier; J Ivanyi
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

2.  Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes.

Authors:  J L Virelizier; A C Allison; G C Schild
Journal:  J Exp Med       Date:  1974-12-01       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.